Bristol-Myers: raises EPS target range for 2020
(CercleFinance.com) - Alongside the publication of its strong quarterly results, Bristol-Myers Squibb has raised its adjusted EPS target range for 2020 to 6.
10-6.25 dollars (vs. 6-6.20 dollars previously).
The pharmaceutical company has reported Q2 adjusted EPS that is up 38% at 1.63 dollar, around 15 cents above the consensus.
Revenues remained stable on a pro-forma basis at 10.1 billion dollars over the period, despite the negative impact of the Covid-19 pandemic, wjhile its gross margin improved by 4.8 points to 73.4%, mainly thanks to its product mix.
Copyright (c) 2020 CercleFinance.com. All rights reserved.